References
- LehmanAFLiebermanJADixonLBAmerican Psychiatric AssociationSteering Committee on Practice GuidelinesPractice guideline for the treatment of patients with schizophreniaSecond editionAm J Psychiatry20041612 Suppl15615000267
- AwadAGSubjective response to neuroleptics in schizophreniaSchizophr Bull1993196096187901897
- AwadAGVorugantiLNPHeslegraveRJThe aims of antipsychotic medications: what are they and are they being achievedCNS Drugs19954816
- RosenstockIMThe health belief model and preventive health behaviourHealth Educ Monogr19742354383
- BebbingtonPEThe content and context of complianceInt Clin Psychopharmacol19959Suppl 541507622833
- AwadAGVorugantiLNPHeslegraveRJHoganTPAssessment of the patient’s subjective experience in acute neuroleptic treatment: implications for compliance and outcomeInt Clin Psychopharmacol199611Suppl 255608803661
- HoganTPAwadAGEastwoodRA self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychol Med1983131771836133297
- WeidenPRapkinBMottTRating of medications influences (ROMI) scale in schizophreniaSchizophr Bull1994202973107916162
- NaberDAA self-rating scale to measure subjective effects of neuro-leptic drugs, relationship to objective psychopathology, quality of life, compliance and other clinical variablesInt Clin Psychopharmacol199510Suppl 31331388866775
- VorugantiLNPAwadAGPersonal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophreniaSchizophr Res200256374612084418
- HoferAKemmlerGEderUHonederMHummerMFleischhackerWWAttitudes toward antipsychotics among outpatient clinic attendees with schizophreniaJ Clin Psychiatry2002631495311838626
- DayJBentallRPRobertsCAttitudes toward antipsychotic medication. the impact of clinical variables and relationships with health professionalsArch Gen Psychiatry20056271772415997012
- GaravanJBrowneSGervinMLaneALarkinCO’CallaghanECompliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and InsightCompr Psychiatry1998392152199675506
- KempRDavidAPsychological predictors of insight and compliance in psychotic patientsBr J Psychiatry19961694444508894195
- SajatovicMRoschDSSivecHJInsight into illness and attitudes toward medications among inpatients with schizophreniaPsychiatr Serv2002531319132112364685
- RossiABagalàADel CuratoloVRemission in schizophrenia: one-year Italian study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorderHum Psychopharmacol (submitted)
- FreudenreichOCatherCEvinsAEHendersonDCGoffDCAttitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insightJ Clin Psychiatry2004651372137615491241
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4thAmerican Psychiatric AssociationWashington DC1994
- KaySRPositive and Negative Syndromes in Schizophrenia: Assessment and Research (Clinical and Experimental Psychiatry)New York, NYBrunner-Mazel Inc1991
- DaneluzzoEArduiniLRinaldiOPANSS factors and scores in schizophrenic and bipolar disorders during an index acute episode: a further analysis of the cognitive componentSchizophr Res20025612913612084427
- EndicottJSpitzerRLFleissJLCohenJThe Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbanceArch Gen Psychiatry197633766771938196
- RossiAArduiniLDe CataldoSStrattaPGli aspetti soggettivi del trattamento con farmaci antipsicotici: studio di validazione della versione italiana della Drug Attitude Inventory (DAI)Epidemiol Psichiatr Soc20011010711311526792
- KaplanDWStructural Equation Modeling: Foundations and ExtensionsSAGE PublicationsCalifornia2000
- HoferAFleischhackerWAttitudes towards medication in patients with schizophreniaActa Psychiatr Scand2006113316116216466401
- AwadGVorugantiLNew antipsychotics, compliance, quality of life, and subjective tolerability. Are patients better offCan J Psychiatry20044929730215198465
- GoldmanHHSkodolAELaveTRRevising axis V for DSM-IV: a review of measures of social functioningAm J Psychiatry1992149114811561386964
- BebbingtonPEAngenermyerMAzorinJMMarwahaSMarteauFToumiMSide-effects of antipsychotic medication and health-related quality of life in schizophreniaActa Psychiatr Scand2009119Suppl 4382228
- ZygmuntAOlfsonMBoyerCAMechanicDIntervention to improve adherence in schizophreniaAm J Psychiatry20021591653166412359668